New preclinical data on allogeneic CAR+TCR-T cells rich in stem cell memory T cells (T SCM ) and enhanced potency to better target solid tumors will be presented at SITC Additional profiling of patient responses in P-BCMA-ALLO1 Phase 1 Arm C and preclinical P-CD19CD20-ALLO1 to be presented at ASH